MARKET

CRBP

CRBP

Corbus Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.040
-0.060
-5.45%
After Hours: 1.040 0 0.00% 18:11 09/24 EDT
OPEN
1.080
PREV CLOSE
1.100
HIGH
1.080
LOW
1.020
VOLUME
895.46K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
0.9100
MARKET CAP
130.24M
P/E (TTM)
-1.2838
1D
5D
1M
3M
1Y
5Y
Cannabis Stocks Gainers And Losers For September 13, 2021
GAINERS: Cipher Pharms Inc (OTC:CPHRF) shares closed up 13.17% at $2.13 with an estimated market cap of $56.4M.
Benzinga · 09/13 20:43
Could The Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Ownership Structure Tell Us Something Useful?
The big shareholder groups in Corbus Pharmaceuticals Holdings, Inc. ( NASDAQ:CRBP ) have power over the company...
Simply Wall St. · 09/10 10:45
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors
marketwatch.com · 09/01 20:46
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
marketwatch.com · 08/31 20:46
Monday's Marijuana Stock Movers
GAINERS: Rhinomed (OTC:RHNMF) shares closed up 10.77% at $0.29 with an estimated market cap of $73.9M.
Benzinga · 08/30 22:58
Cannabis Stocks: Today's Gainers and Losers
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 13.64% at $2.5 with an estimated market cap of $230,523,802.
Benzinga · 08/30 22:52
Arena Pharma, GrowGen & HEXO Among Top Cannabis Stock Movers On August 23, 2021
GAINERS: iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 35.27% at $0.28 with an estimated market cap of $48,870,997.
Benzinga · 08/24 00:02
Corbus Pharmaceuticals Holdings Inc. stock rises Friday, still underperforms market
marketwatch.com · 08/20 20:46
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CRBP. Analyze the recent business situations of Corbus Pharms through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CRBP stock price target is 2.048 with a high estimate of 3.000 and a low estimate of 1.400.
EPS
Institutional Holdings
Institutions: 178
Institutional Holdings: 56.00M
% Owned: 44.71%
Shares Outstanding: 125.23M
TypeInstitutionsShares
Increased
21
12.70M
New
19
2.44M
Decreased
32
8.48M
Sold Out
29
1.09M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.13%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Chairman/Independent Director
Alan Holmer
Chief Executive Officer/Director
Yuval Cohen
Chief Financial Officer
Sean Moran
Other
Craig Millian
Independent Director
Avery Catlin
Independent Director
Rachelle Jacques
Independent Director
John Jenkins
Independent Director
Peter Salzmann
No Data
  • All
  • Financials
  • Insiders
More
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases segment. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and halt fibrotic processes. Lenabasum stimulates the production of Specialized Pro-Resolving Lipid Mediators (SPMs) that act to resolve inflammation, and halt fibrosis by activating endogenous pathways. The Company is developing lenabasum to treat four diseases: systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis and systemic lupus erythematosus (SLE).

Webull offers kinds of Corbus Pharmaceuticals Holdings Inc stock information, including NASDAQ:CRBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRBP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRBP stock methods without spending real money on the virtual paper trading platform.